Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren
Datenschutzerklärungen
.
X
Login
Merkliste (
0
)
Startseite
Über uns
Startseite Über uns
Neues aus der SuUB
Geschichte der SuUB
Bibliotheksprofil
Presseinformationen
Freundeskreis
Die Bibliothek in Zahlen
Ausstellungen
Projekte
Ausbildung, Praktika und Stellenangebote
Filme zur Staats- und Universitätsbibliothek Bremen
Service & Beratung
Startseite Service & Beratung
Ausleihe & Fernleihe
Rückgabe & Verlängerung
Schulungen & Führungen
Mein Bibliothekskonto
Bibliotheksausweis
Neu in der Bibliothek?
Informationsmaterialien, Formulare und Pläne zum Download
Öffnungszeiten
Lernort Bibliothek
PC, WLAN, Kopieren, Scannen, Drucken
Kataloge & Sammlungen
Startseite Kataloge & Sammlungen
Historische Sammlungen
Digitale Sammlungen
Fachinformationen
Standorte
Startseite Standorte
Zentrale
Juridicum
Bereichsbibliothek Wirtschaftswissenschaft
Bereichsbibliothek Physik / Elektrotechnik
Teilbibliothek Technik und Sozialwesen
Teilbibliothek Wirtschaft und Nautik
Teilbibliothek Musik
Teilbibliothek Kunst
Teilbibliothek Bremerhaven
Kontakt
Startseite Kontakt
Liste der Ansprechpartner
Open Access & Publizieren
Startseite Open Access & Publizieren
Literaturverwaltung
Literatur Publizieren
Open Access in Bremen
Toggle navigation
Li, Mu-chun
383
Ergebnisse:
OpenAccess-Volltexte X
Personensuche
X
Sortierung: Relevanz
Sortierung: Jahr
?
1
Development of Furanopyrimidine-Based Orally Active Third-G..:
Li, Mu-Chun
;
Coumar, Mohane Selvaraj
;
Lin, Shu-Yu
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969398/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
2
A critical overview of current progress for COVID-19: devel..:
Kumari, Monika
;
Lu, Ruei-Min
;
Li, Mu-Chun
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465653/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
3
Design of drug-like hepsin inhibitors against prostate canc..:
Blay, Vincent
;
Li, Mu-Chun
;
Ho, Sunita P
...
qt78d0b7w7. , 2020
Link:
https://escholarship.org..
?
4
Design of drug-like hepsin inhibitors against prostate canc..:
Blay, Vincent
;
Li, Mu-Chun
;
Ho, Sunita P
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452031/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
5
A critical overview of current progress for COVID-19: devel..:
Monika Kumari
;
Ruei-Min Lu
;
Mu-Chun Li
...
https://doi.org/10.1186/s12929-022-00852-9. , 2022
Link:
https://doi.org/10.1186/..
?
6
Mimicking H3 Substrate Arginine in the Design of G9a Lysine..:
M. Ramya Chandar Charles
;
Mu-Chun Li
;
Hsing-Pang Hsieh
.
https://doi.org/10.1021/acsomega.0c04710. , 2021
Link:
https://doi.org/10.1021/..
?
7
Design of drug-like hepsin inhibitors against prostate canc..:
Vincent Blay
;
Mu-Chun Li
;
Sunita P. Ho
...
http://www.sciencedirect.com/science/article/pii/S2211383519309566. , 2020
Link:
https://doi.org/10.1016/..
?
8
Mimicking H3 Substrate Arginine in the Design of G9a Lysine..:
M. Ramya Chandar Charles (10180006)
;
Mu-Chun Li (10180009)
;
Hsing-Pang Hsieh (139595)
.
https://figshare.com/articles/dataset/Mimicking_H3_Substrate_Arginine_in_the_Design_of_G9a_Lysine_Methyltransferase_Inhibitors_for_Cancer_Therapy_A_Computational_Study_for_Structure-Based_Drug_Design/14080747. , 2021
Link:
https://doi.org/10.1021/..
?
9
Mimicking H3 Substrate Arginine in the Design of G9a Lysine..:
M. Ramya Chandar Charles (10180006)
;
Mu-Chun Li (10180009)
;
Hsing-Pang Hsieh (139595)
.
https://figshare.com/articles/dataset/Mimicking_H3_Substrate_Arginine_in_the_Design_of_G9a_Lysine_Methyltransferase_Inhibitors_for_Cancer_Therapy_A_Computational_Study_for_Structure-Based_Drug_Design/14080738. , 2021
Link:
https://doi.org/10.1021/..
?
10
Mimicking H3 Substrate Arginine in the Design of G9a Lysine..:
M. Ramya Chandar Charles (10180006)
;
Mu-Chun Li (10180009)
;
Hsing-Pang Hsieh (139595)
.
https://figshare.com/articles/media/Mimicking_H3_Substrate_Arginine_in_the_Design_of_G9a_Lysine_Methyltransferase_Inhibitors_for_Cancer_Therapy_A_Computational_Study_for_Structure-Based_Drug_Design/14080729. , 2021
Link:
https://doi.org/10.1021/..
?
11
Mimicking H3 Substrate Arginine in the Design of G9a Lysine..:
M. Ramya Chandar Charles (10180006)
;
Mu-Chun Li (10180009)
;
Hsing-Pang Hsieh (139595)
.
https://figshare.com/articles/dataset/Mimicking_H3_Substrate_Arginine_in_the_Design_of_G9a_Lysine_Methyltransferase_Inhibitors_for_Cancer_Therapy_A_Computational_Study_for_Structure-Based_Drug_Design/14080741. , 2021
Link:
https://doi.org/10.1021/..
?
12
Mimicking H3 Substrate Arginine in the Design of G9a Lysine..:
M. Ramya Chandar Charles (10180006)
;
Mu-Chun Li (10180009)
;
Hsing-Pang Hsieh (139595)
.
https://figshare.com/articles/journal_contribution/Mimicking_H3_Substrate_Arginine_in_the_Design_of_G9a_Lysine_Methyltransferase_Inhibitors_for_Cancer_Therapy_A_Computational_Study_for_Structure-Based_Drug_Design/14080723. , 2021
Link:
https://doi.org/10.1021/..
?
13
Mimicking H3 Substrate Arginine in the Design of G9a Lysine..:
M. Ramya Chandar Charles (10180006)
;
Mu-Chun Li (10180009)
;
Hsing-Pang Hsieh (139595)
.
https://figshare.com/articles/media/Mimicking_H3_Substrate_Arginine_in_the_Design_of_G9a_Lysine_Methyltransferase_Inhibitors_for_Cancer_Therapy_A_Computational_Study_for_Structure-Based_Drug_Design/14080732. , 2021
Link:
https://doi.org/10.1021/..
?
14
Mimicking H3 Substrate Arginine in the Design of G9a Lysine..:
M. Ramya Chandar Charles (10180006)
;
Mu-Chun Li (10180009)
;
Hsing-Pang Hsieh (139595)
.
https://figshare.com/articles/media/Mimicking_H3_Substrate_Arginine_in_the_Design_of_G9a_Lysine_Methyltransferase_Inhibitors_for_Cancer_Therapy_A_Computational_Study_for_Structure-Based_Drug_Design/14080726. , 2021
Link:
https://doi.org/10.1021/..
?
15
Mimicking H3 Substrate Arginine in the Design of G9a Lysine..:
M. Ramya Chandar Charles (10180006)
;
Mu-Chun Li (10180009)
;
Hsing-Pang Hsieh (139595)
.
https://figshare.com/articles/media/Mimicking_H3_Substrate_Arginine_in_the_Design_of_G9a_Lysine_Methyltransferase_Inhibitors_for_Cancer_Therapy_A_Computational_Study_for_Structure-Based_Drug_Design/14080735. , 2021
Link:
https://doi.org/10.1021/..
1-15
